Maksym Kopanitsa


I was born and educated in Ukraine. I graduated from the Mechnikov Odessa State University with a Diploma in Biology. I received my PhD in Biophysics at the Bogomoletz Institute of Physiology (Kyiv, Ukraine), where I studied pharmacology of voltage- and ligand-gated ion channels and excitatory synaptic transmission. During my postdoctoral appointments at the University of Dundee (2003–2004) and the Wellcome Trust Sanger Institute in Cambridge (2004–2010), I worked with genetically altered mice to study genetic regulation of synaptic transmission in brain slices.

In 2010–2018, I held industrial positions at preclinical CROs Synome Ltd (Cambridge, UK) and Charles River Discovery (Kuopio, Finland). I supervised studies of rodent brain slice electrophysiology and behaviour in a wide range of brain disease models for industrial clients and academic collaborations within several EU FP7 consortia.

In 2018–2020, I worked as Lead for In Vivo Neurobiology at the UK Dementia Research Institute at Imperial College London, supervising and supporting in vitro and in vivo experiments in mouse models of neurodegenerative conditions.

In December 2020, I have joined Cancer Neuroscience group led by Leanne Li at the Crick Institute as Senior Laboratory Research Scientist.

Qualifications and history

Mechnikov Odessa State University, Odessa, Ukraine
Diploma in Biology with Honours
Bogomoletz Institute of Physiology, Kyiv, Ukraine
PhD in Biophysics
Bogomoletz Institute of Physiology, Kyiv, Ukraine
Junior Scientist
University of Dundee
Postdoctoral Researcher
Wellcome Sanger Institute, UK
Postdoctoral Researcher
Synome Ltd, Cambridge, UK
Chief Operating Officer
Charles River Laboratories, Kuopio, Finland
Head of Translational Biology
Imperial College London, London, UK
In Vivo Neurobiology Lead
The Francis Crick Institute, London, UK
SLRS in the Leanne Li group